Blog
IonQ’s Quantum Surge: Ride the Wave or Cash Out?
IonQ (NYSE: IONQ), a quantum computing company founded in 2015, has taken investors on a wild ride this year. The stock has surged 112% in the past month and is now up 40% year-to-date after
Caterpillar Stock: Market Points to a Buying Opportunity
Caterpillar’s (NYSE: CAT) stock price fell sharply following the Q3 release, but the market activity since the initial decline clearly signals that it is time to buy this stock. The Q3
Big Buybacks Announced: 3 Stocks Insiders Are Banking On
Whenever investors think of the factors that can make a stock go up or become more popular in the market, they typically refer to the announcement of a mega investor like Warren Buffett taking a
Chipotle Serves Up a Price Dip - The Market Is Buying
The market for Chipotle Mexican Grill (NYSE: CMG) stock served up a nice dip, and savvy investors are buying. Lackluster results and guidance drove the dip in price action, but the move is
Bitcoin Breakout: 3 Stocks Set to Ride the Cryptocurrency Wave
Now that investors across markets notice the potential for inflation trades returning to popularity, a decent amount of capital is beginning to float into risk assets like commodities and
Charging Ahead: Investing in the EV Charging Infrastructure
The electric vehicle (EV) revolution is in full swing, with millions of EVs already on the road and an estimated 30 to 42 million expected by 2030. This rapid transition from gasoline-powered
Silver Stocks, ETFs, or Bullion: What’s the Best Bet Now?
The spot price of silver is roughly $35 per ounce, just below the highest level in over a decade. Alongside gold, which has repeatedly touched new record highs in recent months, the price of
Applied Materials vs ASML: Which is the Best Chip Stock to Own?
I recently wrote about the largest semiconductor equipment provider in the world, ASML (NASDAQ: ASML). Now, I’ll cover the second largest, Applied Materials (NASDAQ: AMAT). The two stocks have
Top Bill Gates Stock Picks Every Investor Should Know About
Now that the S&P 500 is flirting with its all-time high levels, picking stocks that might outperform in the coming quarters becomes daunting for most investors. Luckily, the top holdings from some
Viking Therapeutics Stock: A Pre-Election Bet Worth Considering
The U.S. presidential election will be held on November 5, 2024, but there’s another event that investors may want to vote on before the election. From November 3 through November 6, the Obesity
Boeing: Why Analysts Think Now's The Time To Be Brave
Boeing Co (NYSE: BA) shares have certainly seen better days, with the ongoing 45% slide from the end of last year speaks volumes. The company is tackling a seemingly never-ending list of
Advanced Micro Devices is Building Momentum with AI: Buy the Dip
As slow as it is to build, Advanced Micro Devices (NASDAQ: AMD) is gaining momentum with AI and is well-positioned for long-term market share gains. The primary hurdle is its AI ecosystem, which
Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Shares of Evolv Technologies Inc. (NASDAQ: EVLV) are down approximately 45% after a group of independent board directors acknowledged accounting irregularities that would delay the company’s
3 ETFs With Low Fees and Market-Beating Returns
The appeal of exchange-traded funds (ETFs) is clear: increase the diversification of your portfolio by targeting a large basket of equities with a single ticker to trade, and leave oversight of
Inflation Threats Make Yield Curve ETFs a Top Trade
Most investors fail to adopt a hybrid attitude toward the stock market. This means some place too much weight on the fundamentals regardless of price action and charts. In contrast, others swear
Double-Digit Gains Ahead? Top 2 Stocks Positioned to Outperform
The economic data has been mixed for the last year but remains sufficient to sustain solid GDP growth, indicating growing activity, which is good news for business services companies. Business
Analysts Believe Cassava Sciences Now Has 300% Upside From Here
Cassava Sciences Inc. (NASDAQ: SAVA) is a biotech developing treatments for Alzheimer's disease. The company has a lot of controversy over its lead drug, simufilam, which attempts to go further
These Are The Top Health Stocks to Own for Buy-and-Hold Investing
Investors looking for health-related buy-and-hold stocks must look no further than this list. The stocks on this list are market leaders in healthcare, producing sustainable growth with healthy
These 3 Dividend ETFs Are Beating the Market in 2024
Beating the market and providing above-market income are two things that don’t always go together, but that’s the case with these three ETFs in 2024. These funds are beating out the just over 23%
3 Stocks With High Short Interest Still Near Their 52-Week Highs
Every stock has bulls and bears. When trying to understand the bearish sentiment around a stock, looking at short interest can be particularly useful. This provides a measurement of how much
Financial Stocks Holding Firm Near Highs: 2 Key Players to Watch
The financial sector has remained resilient, with the Financial Select Sector SPDR Fund (NYSE: XLF) recently breaking out to new 52-week highs after consolidating for a month. Strong earnings at
Upwork Fortifies Profitability Plan With Raised Q3 Forecasts
The world's largest digital freelance platform, Upwork Inc. (NASDAQ: UPWK), took proactive measures ahead of its upcoming third quarter of 2024 earnings release due out Nov. 6, 2024. The company
2 Small Modular Reactor Stocks Racing to Power AI Data Centers
The push by data centers to seek out clean energy sources to power their AI platforms and applications has become mainstream. Data centers are estimated to consume over 9% of all domestic
Oklo Stock: Nuclear Powerhouse or Radioactive Hype?
Oklo (NYSE: OKLO) is at the forefront of developing advanced nuclear fission power plants and nuclear fuel recycling systems. In just the past month, the stock has jumped over 115%, soaring
Is McDonald's Stock a Smart Buy After Sell-Off and Earnings?
Some of the market’s biggest blue-chip stocks are not immune to offering discounts to investors; it’s not that often that participants can exploit the short-term nature of these mispricing events

